Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 3, 2013, Pages 841-852

  Marino, Mariapaola ^a   Scuderi, F ^a   Ponte, E ^b   Maiuri, M T ^a   De Cristofaro, R ^a   Provenzano, C ^a   Rose John, S ^c   Cittadini, A ^a   Bartoccioni, Emanuela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

IL 6; Inflammation; Platelet; STAT3; Trans signaling

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIMYCIN; CANGRELOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 6 RECEPTOR ALPHA; STAT3 PROTEIN; THROMBIN; STAT3 PROTEIN, HUMAN;

ARTICLE; DEGRANULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOSIS; DRUG EFFECT; METABOLISM; PHYSIOLOGY; DRUG EFFECTS;

ADENOSINE DIPHOSPHATE; BLOOD PLATELETS; CALCIMYCIN; HUMANS; INTERLEUKIN-6; PLATELET AGGREGATION; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; THROMBIN;

EID: 84891605223     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Weyrich AS, Lindemann S, Tolley ND, et al. Change in protein phenotype without a nucleus: translational control in platelets. Semin Thromb Hemost 2004; 30:491-8.
2. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25:489-95.
3. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94:3791-9.
4. Kerr R, Stirling D, Ludlam CA. Interleukin 6 and haemostasis. Br J Haematol 2001; 115:3-12.
5. Rose-John S. Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv Exp Med Biol 2001; 495: 45-51.
6. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989; 170:1409-14.
7. Marta RF, Goette NP, Lev PR, Chazarreta CD, Pirola CJ, Molinas FC. Normal platelets possess the soluble form of IL-6 receptor. Cytokine 2005; 29:13-7.
8. Peters M, Blinn G, Solem F, Fischer M, Meyerzum Buschenfelde KH, Rose-John S. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. J Immunol 1998; 161:3575-81.
9. Hurst SM, Wilkinson TS, McLoughlin RM, et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14:705-14.
10. Jostock T, Müllberg J, Özbek S, et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 2001; 268:160-7.
11. Hartwig D, Härtel C, Hennig H, Müller-Steinhardt M, Schlenke P, Klüter H. Evidence for de novo synthesis of cytokines and chemokines in platelet concentrates. Vox Sang 2002; 82:182-90.
12. Petrucci G, De Cristofaro R, Rutella S, et al. Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors. J Pharmacol Exp Ther 2010; 336:391-402.
13. Leytin V, Mody M, Semple JW, Garvey B, Freedman J. Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations. Biochem Biophys Res Commun 2000; 269:85-90.
14. Soslau G, Morgan DA, Jaffe JS, Brodsky I, Wang Y. Cytokine mRNA expression in human platelets and a megakaryocyte cell line and cytokine modulation of platelet function. Cytokine 1997; 9:405-11.
15. Judge HM, Buckland RJ, Holgate CE, Storey RF. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses. Platelets 2005; 16:398-407.
16. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115:3378-84.
17. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010; 38:S26-34.
18. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011; 364:1746-60.
19. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8:1227-34.
20. Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000; 110:925-34.
21. Sadallah S, Eken C, Martin PJ, Schifferli JA. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 2011; 186: 6543-52.
22. Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets. Blood 1996; 87:439-46.
23. Tibbles HE, Vassilev A, Wendorf H, et al. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation. J Biol Chem 2001; 276: 17815-22.
24. Vassilev AO, Lorenz DR, Tibbles HE, Uckun FM. Role of the leukemia-associated transcription factor STAT3 in platelet physiology. Leuk. Lymphoma 2002; 43: 1461-7.
25. Zhou Z, Gushiken FC, Bolgiano D, et al. Signal Transducer and Activator of Transcription 3 (STAT3) Regulates Collagen-Induced Platelet Aggregation Independently of Its Transcription Factor Activity. Circulation 2013; 127:476-85.
26. Stalker TJ, Traxler EA, Wu J, Wannemacher KM, Cermignano SL, Voronov R, Diamond SL, Brass LF. Hierarchical organization in the hemostatic response and its relationship to the platelet signaling network. Blood 2013; 121:1875-85.
27. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24:25-9.
28. Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kübler W, Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler Thromb Vasc Biol 2002; 22:914-20.
29. Chalaris A, Rabe B, Paliga K, et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory transsignaling function of neutrophils. Blood 2007; 110:1748-55.
30. Badr Eslam R, Lang IM, Kaider A, Panzer S. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition. Transl Res 2013; 161:414-20.